NCT06377189 Psychiatric Consultation-Liaison Intervention in Primary Care: A Pilot Study
| NCT ID | NCT06377189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland |
| Condition | Mental Health Issue |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-05-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The pilot study on the impact of a Psychiatric Consultation-Liaison Intervention in Primary Care Medical Consultations in French-speaking Switzerland (PLIMeC-P), is a mixed method randomized controlled trial. The investigated health-related intervention is a brief Consultation-Liaison (CL) psychiatry intervention in primary care. Primary Care Physicians (PCPs) have a key role in preventing, detecting, and managing mental disorders. Therefore, the optimization of both the quality of their interventions and their cooperation with psychiatric and psychological care networks are important challenges. It is well demonstrated that multidisciplinary interventions improve the efficacy of mental health care, CL psychiatry being one such type of intervention. Therefore, community CL-psychiatry, for example in private primary care group practices, are rare. The impact of such community, primary care CL-psychiatry interventions, should be investigated. The mixed methods randomized controlled trial PLIMeC study will examine the impact of a CL-psychiatric intervention in primary care settings, for newly reported mental illness, versus a Treatment As Usual (TAU) control arm. The intervention consists of a CL-psychiatric intervention into private medical practices, provided to patients suffering from mental health problems, a group of patients generally under-treated. The CL-psychiatrist will receive and discuss PCPs' referrals for patients with mental distress, who don't have a psychiatric follow-up. After a brief intervention (1-4 sessions), feedback conjoint (PCP-psychiatrist) session will be organized, to complete the intervention and provide proposals. The pilot study (PLIMeC-P) will determine whether the main planned study (PLIMeC) is feasible and practicable. It will be conducted on two sites, the Neuchâtel Psychiatry Centre (CNP) and the North-west Adult Psychiatry Service (SPANO), Department of Psychiatry of CHUV, Yverdon. For the pilot study (PLIMeC-P), 15 eligible participants are expected for each group, 30 participants in total. They will be recruited in three private primary care group practices. After eligibility and randomization 15 participants will be included for the intervention arm (brief CL-psychiatric intervention) and 15 for the control arm (TAU). The expected number of participants for the main trial (PLIMeC) will be estimated through analysis of the initial results of the PLIMeC-P.
Eligibility Criteria
Inclusion Criteria: * Aged more than 18 years * Signed informed consent to study protocol * Referred by their PCP due to mental distress, psychiatric symptoms, or complexity of medical care * Having fluent knowledge of the local language or being accompanied by an interpreter Exclusion Criteria: * Not being able to give an informed consent and follow the procedure of the study (due to dementia, restriction of intellectual capacity, acute confusional state, language problem) * Presenting an acute psychotic symptomatology, a hetero-aggression risk or an acute suicidality * Having an ongoing psychiatric follow-up
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06377189 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mental Health Issue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06377189 currently recruiting?
Yes, NCT06377189 is actively recruiting participants. Contact the research team at konstantinos.tzartzas@unisante.ch for enrollment information.
Where is the NCT06377189 trial being conducted?
This trial is being conducted at Neuchâtel, Switzerland, Lausanne, Switzerland, Yverdon-les-Bains, Switzerland.
Who is sponsoring the NCT06377189 clinical trial?
NCT06377189 is sponsored by Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland. The trial plans to enroll 30 participants.